학술논문
Results of a Phase 2, Randomized, Double-Blind Study of Sorafenib Versus Placebo in Combination with Intensive Chemotherapy in Previously Untreated Patients with FLT3-ITD Acute Myeloid Leukemia (ALLG AMLM16)
Document Type
Abstract
Author
Wei, Andrew H; Kennedy, Glen A ; Morris, Kirk L; Grigg, Andrew ; He, Simon ; Schwarer, Anthony ; Ting, Stephen B ; Enjeti, Anoop Kumar; Yuen, Sam; D'Rozario, James; Latimer, Maya ; Marlton, Paula; Bilmon, Ian ; Taper, John ; Cull, Gavin; Tiley, Campbell ; Verner, Emma ; Hahn, Uwe H ; Hiwase, Devendra K; Iland, Harry ; Murphy, Nichloas ; Ravanathan, Sundra ; Nguyen, Uyen ; Ong, Doen Ming ; Loo, Sun ; Tiong, Ing-Soo ; Wall, Meaghan ; Anstee, Natasha S ; Levis, Mark; Murray, Michael ; Rawling, Tristan ; Leadbetter, Joanna ; Bajel, Ashish; Roberts, Andrew W
Source
In Blood 5 November 2020 136 Supplement 1:36-38
Subject
Language
ISSN
0006-4971